Abstract:Yating Zhang, 1 Hongyan Wang, 1 Jie Yang, 2 Sanchun Wang, 1 Weifang Tong, 1 Bo Teng 1 1 Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China; 2 Department of Neurology, the First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China Correspondence: Bo Teng, Department of Otorhinolaryngology Head and Neck Surgery, the Second Hospital of Jilin University, No. 218 Ziqiang Street, Nanguan District, Changchun, Jilin Province, 130000, People's Republic of China, Email Purpose: This investigation sought to elucidate the genetic underpinnings that connect obesity indicators, circulating blood lipid levels, adipokines levels and obstructive sleep apnea syndrome (OSAS), employing a bidirectional two-sample Mendelian randomization (MR) analysis that utilizes data derived from extensive genome-wide association studies (GWAS). Methods: We harnessed genetic datasets of OSAS available from the FinnGen consortium and summary data of four obesity indices (including neck circumference), seven blood lipid (including triglycerides) and eleven adipokines (including leptin) from the IEU OpenGWAS database. We primarily utilized inverse variance weighted (IVW), weighted median, and MR-Egger methods, alongside MR-PRESSO and Cochran's Q tests, to validate and assess the diversity and heterogeneity of our findings. Results: After applying the Bonferroni correction, we identified significant correlations between OSAS and increased neck circumference (Odds Ratio [OR]: 3.472, 95% Confidence Interval [CI]: 1.954– 6.169, P= 2.201E-05) and decreased high-density lipoprotein (HDL) cholesterol levels (OR: 0.904, 95% CI: 0.858– 0.952, P= 1.251E-04). Concurrently, OSAS was linked to lower leptin levels (OR: 1.355, 95% CI: 1.069– 1.718, P= 0.012) and leptin receptor levels (OR: 0.722, 95% CI: 0.530– 0.996, P= 0.047). Sensitivity analyses revealed heterogeneity in HDL cholesterol and leptin indicators, but further multiplicative random effects IVW method analysis confirmed these correlations as significant (P< 0.05) without notable heterogeneity or horizontal pleiotropy in other instrumental variables. Conclusion: This investigation compellingly supports the hypothesis that OSAS could be a genetic predisposition for elevated neck circumference, dyslipidemia, and adipokine imbalance. These findings unveil potential genetic interactions between OSAS and metabolic syndrome, providing new pathways for research in this domain. Future investigations should aim to delineate the specific biological pathways by which OSAS impacts metabolic syndrome. Understanding these mechanisms is critical for developing targeted prevention and therapeutic strategies. Keywords: sleep disorders, metabolic syndrome, causal inference, GWAS Obstructive sleep apnea syndrome (OSAS) represents a multifaceted disorder with intricate pathophysiological characteristics. It is principally marked by nocturnal sleep snoring with apnea and daytime somnolence. The pathogenesis of OSAS predominantly involves partial or complete obstruction of the upper airway during sleep, culminating in intermittent hypoxia (IH) and sleep fragmentation. 1 Concurrent with the global rise in obesity rates, the incidence of OSAS has escalated markedly, eliciting considerable public health concern. Empirical evidence suggests that obesity is a principal risk factor for OSAS, with its prevalence in obese cohorts reaching up to 30%, in stark contrast to the 2–4% in the general population. This prevalence escalates to an alarming 50–98% in severely obese individuals. 2 Furthermore, OSAS is intricately linked with increased sympathetic nervous activity, systemic inflammation, oxidative stress and endothelial dysfunction. These elements, in conjunction with obesity, synergistically contribute to the pathogenesis and progression of associated complications, including metabolic syndrome and cardiovascular diseases. 3,4 Additionally, obesity-induced disturbances in adipokine metabolism, abnormalities in C-reactive protein (CRP) and an increase in other cardiovascular risk markers, are pivotal in the development and progression of OSAS and its complications. While clinical research has identified associations between obesity, dyslipidemia, adipokines and OSAS, these studies grapple with confounding factors and reverse causality, leading to contentious findings. To mitigate these issues, our study adopts a Mendelian randomization (MR) approach within epidemiological research, utilizing a spectrum of genetic variants as instrumental variables (IVs) for causal inference. 5 MR studie -Abstract Truncated-

Application Value of Cardiometabolic Index for the Screening of Obstructive Sleep Apnea with or Without Metabolic Syndrome

Evaluate the Relationship Between Obstructive Sleep Apnea and Metabolic Syndrome in Real-World Data

Obstructive Sleep Apnea in Metabolic Syndrome

A Machine Learning Prediction Model of Adult Obstructive Sleep Apnea Based on Systematically Evaluated Common Clinical Biochemical Indicators

THE METABOLIC SCORE FOR INSULIN RESISTANCE (METS-IR) PREDICTS CARDIOVASCULAR DISEASE AND ITS SUBTYPES IN PATIENTS WITH HYPERTENSION AND OBSTRUCTVE SLEEP APNEA

Association of Metabolic Syndrome With Long-Term Cardiovascular Risks and All-Cause Mortality in Elderly Patients With Obstructive Sleep Apnea

Obstructive sleep apnea syndrome is associated with metabolic syndrome

Comorbid Obstructive Sleep Apnea is Associated with Adverse Cardiovascular Outcomes in Female Patients with Acute Coronary Syndrome Complicating Metabolic Syndrome.

Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study

Impact of obstructive sleep apnea on prognosis of patients with cardiometabolic multimorbidity

[Obstructive Sleep Apnea and Metabolic Syndrome: an Association Study Based on a Large Sample Clinical Database].

The association between obstructive sleep apnea and metabolic syndrome: a systematic review and meta-analysis

Metabolomic profiles predict clinical severity in patients with obstructive sleep apnea-hypopnea syndrome

An Effective Model for Screening Obstructive Sleep Apnea: A Large-Scale Diagnostic Study

The Association Between Obstructive Sleep Apnea Syndrome and Metabolic Syndrome: a Confirmatory Factor Analysis

Analysis on Correlation Between Obstructive Sleep Apnea Hypopnea and Metabolic Syndromes in Male Patients

[Prevalence of metabolic syndrome in adult patients with obstructive sleep apnea syndrome]

Relationships Between Cardiometabolic Disorders and Obstructive Sleep Apnea: Implications for Cardiovascular Disease Risk

Identifying Metabolic Syndrome Easily and Cost Effectively Using Non-Invasive Methods with Machine Learning Models

Obstructive Sleep Apnea Syndrome and Obesity Indicators, Circulating Blood Lipid Levels, and Adipokines Levels: A Bidirectional Two-Sample Mendelian Randomization Study

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome